Big drugmakers made at least $5bn in US tax savings in 2025

The significant tax savings reported by big drugmakers underscore a growing trend among multinational corporations to exploit loopholes in the tax system. While such strategies can enhance profitability, they also provoke public outcry regarding the ethical responsibilities of these companies, especially in the healthcare sector. As scrutiny increases, it remains to be seen how lawmakers will respond to these practices and whether reforms will be implemented to ensure a fairer tax system.